首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Four missense mutations identified in the protein S gene of thrombosis patients with protein S deficiency: effects on secretion and anticoagulant activity of protein S.
【24h】

Four missense mutations identified in the protein S gene of thrombosis patients with protein S deficiency: effects on secretion and anticoagulant activity of protein S.

机译:在缺乏蛋白S的血栓形成患者的蛋白S基因中鉴定出四个错义突变:对蛋白S的分泌和抗凝活性的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Four missense mutations, G54R, T589I, K155E, and Y595C, were identified in the protein S (PS) gene of the patients with PS deficiency and venous thrombosis. Three patients were heterozygous for the novel mutations, G54R, T589I, and Y595C, while a remaining one patient was homozygous for the K155E mutation, which is known to be a polymorphism in the Japanese population. A family study revealed that the Y595C mutation was associated with a Type I PS deficiency and the K155E mutation with a Type II PS deficiency, while no family study was performed for the patients with the G54R and T589I mutations. To determine whether these four mutations play a causative role in PS deficiency, the four PS mutants and wild-type PS were stably expressed in human embryo kidney (HEK) 293 cells. Pulse-chase experiments showed intracellular degradation and decreased secretion of the Y595C mutant. In the activated protein C (APC) cofactor assays, the specific activity of the K155E mutant decreased to 58% of that of wild-type PS. The APC cofactor activity of the three mutants, G54R, K155E, and T589I, were inhibited by C4b-binding protein (C4BP) with a dose dependency similar to that of wild-type PS. These results indicate that the Y595C and the K155E mutations are responsible for a secretion defect and a decreased anticoagulant activity of PS, respectively. The remaining two mutations, G54R and T589I, however, did not produce any definite abnormality leading to a low plasma PS activity.
机译:在PS缺乏和静脉血栓形成的患者的蛋白S(PS)基因中鉴定出四个错义突变G54R,T589I,K155E和Y595C。 3例患者的新突变为G54R,T589I和Y595C,为纯合子,其余1例患者的K155E突变为纯合子,K155E突变在日本人群中是多态性。一项家庭研究表明,Y595C突变与I型PS缺乏症相关,而K155E突变与II型PS缺乏症相关,而对G54R和T589I突变的患者未进行家族研究。为了确定这四个突变是否在PS缺乏症中起致病作用,在人胚肾(HEK)293细胞中稳定表达了这四个PS突变体和野生型PS。脉冲追踪实验显示Y595C突变体的细胞内降解和分泌减少。在活化的蛋白C(APC)辅助因子测定中,K155E突变体的比活性降至野生型PS的58%。 C4b结合蛋白(C4BP)抑制了三个突变体G54R,K155E和T589I的APC辅因子活性,其剂量依赖性与野生型PS相似。这些结果表明Y595C和K155E突变分别负责PS的分泌缺陷和降低的抗凝活性。但是,其余的两个突变G54R和T589I没有产生任何确定的异常,导致血浆PS活性低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号